AMOXIL

This brand name is authorized in Australia, Brazil, Cyprus, Ecuador, Ireland, Lithuania, Malta, Mexico, Nigeria, New Zealand, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug AMOXIL contains one active pharmaceutical ingredient (API):

1 Amoxicillin UNII 804826J2HU - AMOXICILLIN

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. Read about Amoxicillin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMOXIL Capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01CA04	Amoxicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11947T, 11998L, 1884E, 1886G, 1887H, 1888J, 1889K, 3300Q, 3301R, 3302T, 3310F, 3393N, 9714G
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510600604119314, 510600605115312, 510600606111310, 510613020049703, 510613020049803, 510613020049903, 510619040060503, 510619040060603
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28909-06-09, 29133-01-10, 29185-02-10
Country: IE	Health Products Regulatory Authority	Identifier(s): 70440, 90522, 90735
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004134, 1033593, 1033594, 1057512, 1057513, 1057514
Country: MT	Medicines Authority	Identifier(s): MA192/03101, MA192/03201, PI908/25901A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 133M99, 208M99
Country: NG	Registered Drug Product Database	Identifier(s): 04-2508
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1687, 1688
Country: SG	Health Sciences Authority	Identifier(s): 01897P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9093351, 9093352, 9093353
Country: US	FDA, National Drug Code	Identifier(s): 61919-041, 61919-135, 61919-716
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/20.1.2/75, J/20.1.2/29